zatebradine has been researched along with Cardiovascular Stroke in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertl, G; Fraccarollo, D; Gaudron, P; Hu, K; Kaden, JJ; Naumann, A; Neubauer, S | 1 |
| Heusch, G; Rose, J; Schulz, R; Skyschally, A | 1 |
| Aidonidis, I; Brachmann, J; Kübler, W; Rizos, I; Stavridis, I; Toutouzas, P; Zacharoulis, A | 1 |
| Ehmke, H; Haass, M; Krüger, C; Kübler, W; Landerer, V; Zugck, C | 1 |
| van der Giessen, WJ; van Woerkens, LJ; Verdouw, PD | 1 |
5 other study(ies) available for zatebradine and Cardiovascular Stroke
| Article | Year |
|---|---|
Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
Topics: Animals; Benzazepines; Body Weight; Cardiotonic Agents; Catecholamines; Chromatography, High Pressure Liquid; Creatine Kinase; Dilatation, Pathologic; Dose-Response Relationship, Drug; Energy Metabolism; Female; Heart Rate; Hemodynamics; Hormones; Isoenzymes; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardium; Oxygen Consumption; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
Topics: Adenosine Triphosphate; Animals; Atenolol; Benzazepines; Blood Pressure; Bradycardia; Cardiovascular Agents; Coronary Circulation; Disease Models, Animal; Female; Heart; Heart Rate; Injections, Intravenous; Lactates; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Phosphocreatine; Reperfusion Injury; Swine; Swine, Miniature | 1995 |
Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Blood Pressure; Cardiotonic Agents; Clonidine; Coronary Vessels; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Evoked Potentials; Female; Male; Myocardial Infarction; Refractory Period, Electrophysiological; Tachycardia, Ventricular | 1995 |
The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction.
Topics: Analysis of Variance; Animals; Baroreflex; Benzazepines; Cardiotonic Agents; Heart; Heart Rate; Linear Models; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2000 |
The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion.
Topics: Animals; Benzazepines; Cardiovascular Agents; Female; Hemodynamics; Male; Myocardial Infarction; Swine; Ventricular Function, Left | 1992 |